Once-daily extended-release niacin lowers serum phosphorus concentrations in patients with metabolic syndrome dyslipidemia

Susie Hu, Gregory C. Shearer, Michael W. Steffes, William S. Harris, Andrew G. Bostom

Research output: Contribution to journalLetterpeer-review

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)181-182
Number of pages2
JournalAmerican Journal of Kidney Diseases
Volume57
Issue number1
DOIs
StatePublished - Jan 2011

Bibliographical note

Funding Information:
Support: Funding for the phosphorus assays was provided by a grant to Dr Hu from the Brown University Foundation for Health , project no. 8791 . The parent study, Niacin, n-3 Fatty Acids and Insulin Resistance ( ClinicalTrials.gov registration no. NCT00286234 ), was funded through a National Institute of Diabetes and Digestive and Kidney Diseases grant to Dr Harris. Placebos and pharmaceuticals were provided by Abbott Laboratories and GlaxoSmithKline. Dr Shearer receives research support from GlaxoSmithKline .

Cite this